Language selection

Search

2008-07-10 - Male - 18 Years old

309094

Adverse reaction report number 309094
Latest AER version number 0
Market authorization holder AER number N/A
Initial received date 2008-07-10
Latest received date 2008-07-10
Age 18 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Consumer Or Other Non Health Professional
Source of report Community
Report outcome Unknown
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 30MGCAPSULE, EXTENDED RELEASESuspectOral60 Milligram1 every 1 Day(s)3 Year(s)Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Asthenia
Confusional state
Drug dependence
Eye disorder
Feeling abnormal
Indifference
Somnolence
Date modified: